Xulane 150-35 MCG/day patch 3S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Q53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,328
Award facts
- Contract value 100% obligated
- $28,328.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,328.39 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity 3) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates capability in delivering a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. This delivery order for contraceptive patches exemplifies the routine pharmaceutical procurement supported through AmerisourceBergen's prime vendor relationship with DLA, enabling efficient supply of medical commodities to defense and federal healthcare customers worldwide.
Quick answers
Who was awarded contract SPE2DR26F5Q53?
SPE2DR26F5Q53 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F5Q53 worth?
The government has obligated $28,328 on SPE2DR26F5Q53.
Is contract SPE2DR26F5Q53 an order under another contract?
Yes. SPE2DR26F5Q53 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Q53 competed?
The extent of competition for SPE2DR26F5Q53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award